Staphylococcus aureus strain FDA209P1

TA loci of Staphylococcus aureus strain FDA209P

Number of TA loci: experimental0; insolico20

TA ID Related MGEs Organism (replicon) Genome accession Toxin Antitoxin Family/Domain
in_silico TA279179 Prophage Staphylococcus aureus strain FDA209P (chromosome) NZ_CP123853 NUG19_RS00100 (txpA) - (SprF1) txpA-SprF1/-
in_silico TA279181 Prophage Staphylococcus aureus strain FDA209P (chromosome) NZ_CP123853 NUG19_RS00100 (txpA) - (SprF1) txpA-SprF1/-
in_silico TA279186 - Staphylococcus aureus strain FDA209P (chromosome) NZ_CP123853 NUG19_RS11415 (SprA2) - (SprA2AS) SprA2-SprA2AS/-
in_silico TA031019 Prophage Staphylococcus aureus strain FDA209P (chromosome) NZ_AP014942 SAFDA_RS14645 (txpA) - (SprF1) txpA-SprF1/-
in_silico TA031020 Prophage Staphylococcus aureus strain FDA209P (chromosome) NZ_AP014942 SAFDA_RS14645 (txpA) - (SprF3) txpA-SprF3/-
in_silico TA031025 - Staphylococcus aureus strain FDA209P (chromosome) NZ_AP014942 SAFDA_RS12535 (SprA2) - (SprA2AS) SprA2-SprA2AS/-
experimentalExperimentally validated     insolicoBioinformatically predicted